The effects of Quercetin supplementation on cardiometabolic outcomes: An umbrella review of meta‐analyses of randomized controlled trials
Phytotherapy Research · 2023-11 · 37 (11) · 5080-5091
DOI: 10.1002/ptr.7971 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Phytotherapy Research, 2023-09. Verfasst von Seyyed Mostafa Arabi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Insulins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Background
Quercetin is a bioactive flavonoid, but the effect of it on cardiometabolic factors has remained uncertain and previous findings from meta‐analyses have been controversial.
Objective
To provide an overview of the effects of Quercetin on cardiometabolic factors based on meta‐analyses of randomized controlled trials (RCTs).
Method
MEDLINE, SciVerse Scopus, and Clarivate Analytics Web of Science databases were searched to identify eligible publications. As part of the umbrella review, we summarized pooled estimates, 95% CIs, heterogeneity, and publication bias. A GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach was used to rate the certainty of evidence.
Results
Five meta‐analyses including 18 eligible RCTs plus 5 RCTs that were not included in previous meta‐analyses were found. The results indicated Quercetin does not affect diastolic blood pressure (DBP), lipid profile, inflammation, anthropometric indices, fasting plasma glucose (FBG), and homeostatic model assessment for insulin resistance (HOMA‐IR). However, Quercetin supplementation could significantly reduce systolic blood pressure (SBP) (weighted mean difference (WMD): −1.9, 95% CI = −3.2 to −0.6, I 2 = 88.3%) and insulin level (WMD: −1.07, 95% CI = −1.9 to −0.1, I 2 = 75.0%). The certainty of evidence ranged from very low to moderate.
Conclusion
Quercetin supplementation has reducing effects on SBP and insulin levels but not other cardiometabolic parameters. More high‐quality trials with longer follow‐up durations may be required to obtain a more robust conclusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran.
- Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Nutrition, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
- Institute for Atherosclerosis Research, Moscow, Russia.
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Amirhossein Sahebkar
Förderung
- Russian Science Foundation
Zitieren
APA
Arabi, S. M., Shahraki Jazinaki, M., Chambari, M., Bahrami, L. S., Maleki, M., Sukhorukov, V. N., & Sahebkar, A. (2023). The effects of Quercetin supplementation on cardiometabolic outcomes: An umbrella review of meta‐analyses of randomized controlled trials. Phytotherapy Research, 37(11), 5080-5091. https://doi.org/10.1002/ptr.7971
Vancouver
Arabi SM, Shahraki Jazinaki M, Chambari M, Bahrami LS, Maleki M, Sukhorukov VN, et al. The effects of Quercetin supplementation on cardiometabolic outcomes: An umbrella review of meta‐analyses of randomized controlled trials. Phytotherapy Research. 2023;37(11):5080-5091. doi:10.1002/ptr.7971
BibTeX
@article{Arabi2023,
author = {Arabi, Seyyed Mostafa and Shahraki Jazinaki, Mostafa and Chambari, Mahla and Bahrami, Leila Sadat and Maleki, Mohsen and Sukhorukov, Vasily N and Sahebkar, Amirhossein},
title = {The effects of Quercetin supplementation on cardiometabolic outcomes: An umbrella review of meta‐analyses of randomized controlled trials},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {11},
pages = {5080--5091},
doi = {10.1002/ptr.7971}
}
EUVIMED